Weekly basal insulin efsitora effective for managing type 2 diabetes

1. In patients with type 2 diabetes mellitus (T2DM) who had not previously been on insulin therapy, once-weekly fixed-dose insulin efsitora was noninferior to daily insulin glargine in reducing glycated hemoglobin (HbA1c) levels by 52 weeks. 2. Insulin efsitora was associated with less clinically significant hypoglycemia and lower total weekly insulin dose, compared to insulin glargine. […]